Researchers find that most Medicare patients wait weeks before breast cancer surgery

November 19, 2012

Although patients may feel anxious waiting weeks from the time of their first doctor visit to evaluate their breast until they have breast cancer surgery, new findings from Fox Chase Cancer Center show that these waits are typical in the United States. Results were published on Monday, November 19 in the Journal of Clinical Oncology.

Looking at data collected from more than 72,000 diagnosed with non-, researchers—led by Richard J. Bleicher, M.D., attending surgeon and director of the Breast Fellowship Program at Fox Chase—found that, in 2005, half of the underwent at least 32 days after first consulting their doctor about their breast problem. This is an increase from 1992, when half of the patients waited no more than 21 days.

"For many patients, it can take a month or more from the time they first see their doctor to evaluate their breast concern, make a diagnosis, and get them to the ," says Bleicher. "So if a woman learns that her surgery date is weeks after her evaluation, where she was found to have a breast cancer, she should know this length of time is typical, and should not be concerned."

"Although this interval may sound alarming at first, it does not appear to have a detrimental effect on outcomes. We don't have the outcomes data for this group of patients yet, but we have seen improvements in survival over the past few decades in breast cancer overall." Bleicher adds.

Before this study, Bleicher explains, it was unclear how long people were actually waiting for surgery and how the surgery type and workup affected that wait. Experts had data from individual institutions, but nothing that captured nationwide. So when patients got anxious hearing their surgery was weeks away, doctors were unable to tell them whether such were longer than the norm, and thus potentially dangerous.

"It's not clear why people are waiting longer for surgery," says Bleicher. Now that patients have access to more information about cancer, they may take longer to make decisions about surgery; alternatively, a larger patient population could be filling operating rooms, making it harder to schedule surgeries. Indeed, patients undergoing more complicated procedures—such as mastectomy with breast reconstruction—waited longer than average.

Longer delays were also seen in patients who received certain types of biopsies and imaging. This suggests that part of the increase in wait time may stem from greater use of a wider variety of current tools to detect and image the tumors before surgery, says Bleicher. This may also explain why patients may be living longer, even though the time from presentation to their doctor until surgery steadily increased from 1992 to 2005.

"Patients should be aware that even though feels like an emergency needing to be addressed tomorrow, it doesn't have to be dealt with in a matter of days," says Bleicher. "These results should reassure women that, if they are not in the operating room tomorrow, that's typical."

He adds that the findings apply only to patients receiving Medicare, and wait times may differ for those with private insurance or no insurance at all.

Even within the Medicare population, there was some variation – wait times were longer for women (29 days, versus 24 days for men), younger patients (29 days), blacks and Hispanics (37 days each), people living in large metropolitan areas and the northeast (32 and 33 days, respectively).

"Although these results suggest that doctors and shouldn't be concerned about small delays in getting to surgery, we need to continue to monitor how long people are waiting," says Bleicher. "Researchers must ensure that this time interval doesn't increase dramatically or start to affect outcomes in certain patient groups, particularly those who already wait longer than the average."

Explore further: Researchers find no disparities in imaging before breast cancer surgery

Related Stories

Researchers find no disparities in imaging before breast cancer surgery

May 17, 2012
If racial and ethnic disparities in breast cancer exist, they are not due to differences in the use of imaging to assess the extent of tumors before surgery, according to new findings that will be presented by Fox Chase Cancer ...

Breast cancer patients face increasing number of imaging visits before surgery

December 9, 2011
Breast cancer patients frequently undergo imaging like mammograms or ultrasounds between their first breast cancer-related doctor visit and surgery to remove the tumor. Evaluations of these scans help physicians understand ...

Recurring cancers in women with a history of breast cancer differ from the original tumors

May 18, 2011
When women with a history of breast cancer learn they have breast cancer again, one of the first questions they and their doctors ask is: Has my cancer come back, or is this a new case? Now, new data from Fox Chase Cancer ...

Most breast cancer patients do not have breast reconstruction surgery

October 20, 2011
Only seven per cent of female breast cancer patients opt for breast reconstruction surgery.

Recommended for you

Study may explain failure of retinoic acid trials against breast cancer

July 25, 2017
Estrogen-positive breast cancers are often treated with anti-estrogen therapies. But about half of these cancers contain a subpopulation of cells marked by the protein cytokeratin 5 (CK5), which resists treatment—and breast ...

Physical activity could combat fatigue, cognitive decline in cancer survivors

July 25, 2017
A new study indicates that cancer patients and survivors have a ready weapon against fatigue and "chemo brain": a brisk walk.

Breaking the genetic resistance of lung cancer and melanoma

July 25, 2017
Researchers from Monash University and the Memorial Sloan Kettering Cancer Center (MSKCC, New York) have discovered why some cancers – particularly lung cancer and melanoma – are able to quickly develop deadly resistance ...

New therapeutic approach for difficult-to-treat subtype of ovarian cancer identified

July 24, 2017
A potential new therapeutic strategy for a difficult-to-treat form of ovarian cancer has been discovered by Wistar scientists. The findings were published online in Nature Cell Biology.

Immune cells the missing ingredient in new bladder cancer treatment

July 24, 2017
New research offers a possible explanation for why a new type of cancer treatment hasn't been working as expected against bladder cancer.

Anti-cancer chemotherapeutic agent inhibits glioblastoma growth and radiation resistance

July 24, 2017
Glioblastoma is a primary brain tumor with dismal survival rates, even after treatment with surgery, chemotherapy and radiation. A small subpopulation of tumor cells—glioma stem cells—is responsible for glioblastoma's ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.